The Plastic Surgeon's Verdict: Gender Surgery Is Mutilation, Not Medicine - Dr.Patrick Lappert (#30)
18 August 2025
With Dr. Patrick Lappert
Global
Dr. Patrick Lappert, a board-certified plastic and reconstructive surgeon with more than four decades of experience, argues that gender surgeries rest on the lowest tier of medical evidence, violate the ethical foundations of his specialty, and expose patients to serious complications that are not adequately disclosed beforehand. His testimony carries direct relevance for Ireland, where the HSE is reviewing its gender services and where patients are routinely referred abroad for procedures unavailable domestically.
Dr. Patrick Lappert spent more than four decades as a plastic and reconstructive surgeon, first in the United States Navy and subsequently in civilian practice, where his work centred on repairing bodies after trauma and disease. In this episode he argues that gender surgeries represent a fundamental departure from that tradition, and that the specialty as a whole has been too slow to acknowledge it publicly. The evidence base is where Lappert begins. He identifies gender surgery as operating on Level 5 evidence — expert opinion, the weakest category recognised in evidence-based medicine — while being presented to patients and policymakers as standard of care. That framing should give pause to anyone making decisions about clinical referral pathways in Ireland, where the HSE's own governance frameworks are built around the principle that interventions must be grounded in the best available evidence. He then moves into clinical specifics. Phalloplasty, he explains, produces a structure that lacks the function it is meant to replicate. Vaginoplasty carries a significant risk of fistula formation, through which faecal matter can enter the surgical site. Chest masculinisation in female patients severs the nerve pathway responsible for sensations that are later central to maternal bonding. These are not remote or theoretical risks; they are outcomes that a clinician referring an Irish patient abroad for surgery unavailable domestically would need to disclose in a manner that satisfies the legal standard of informed consent. Lappert places the condition driving patients toward surgery in a different diagnostic category from the one gender medicine uses. He argues it is consistent with body dysmorphic disorder — a recognised psychiatric condition for which plastic surgery is considered ethically prohibited, precisely because the intervention targets the patient's perception of the body rather than the underlying psychological state. That argument challenges the foundational logic of gender medicine and raises questions about how Irish healthcare institutions have evaluated the procedures they facilitate or fund. Swedish registry data cited in the episode shows suicide rates among those who had undergone surgical transition running approximately forty times higher than in the general population. That figure has direct implications for how outcomes should be measured and reported, and for the completeness of the case made to patients before they consent. It also raises a question Irish health services have not fully resolved: who is responsible for long-term follow-up of patients referred abroad for irreversible procedures, and over what timeframe? Lappert is explicit about younger patients. He argues that adolescents are not capable of grasping the permanence or the functional consequences of these surgeries. In Ireland, consent for medical treatment involving minors is governed by statute and evolving case law. Whether existing standards are adequate when the procedure is irreversible and the evidence base is as weak as Lappert describes is a question Irish clinicians, regulators and legislators are yet to answer in full.
